An Incisive, In-depth Analysis on the Renal Biomarker Market
This study offers a comprehensive, 360 degree analysis on the Renal Biomarker market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Renal Biomarker market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Kidney diseases are one of the leading causes of death worldwide. The incidence of chronic kidney diseases is rapidly rising especially in the elderly population due to increase in life expectancy of general population and improvements in medical management services. However, diabetes and hypertension remain the leading cause of renal diseases. Biomarkers are measurable indicators reflecting physiological and pharmacological progression of disease state. Recent advances in molecular biology have resulted in the development of novel biomarkers for the renal function. Extensive R&D by biomarker manufacturers has led to identification of novel renal biomarkers to deliver better diagnostic accuracy and improve patient outcomes.
Revenue from the global renal biomarker market is projected to register a CAGR of 7.0% during the forecast period (2016 – 2026) and reach a market valuation of US$ 1,770.3 Mn by the end of 2026.
Rising prevalence of renal diseases primary driver boosting market growth
Growth of the global renal biomarker market is mainly driven by rising prevalence of various renal diseases coupled with an ageing population worldwide. Also, there has been an increase in the adult population with chronic kidney diseases, primarily attributed to a rising prevalence of conditions such as diabetes and high blood pressure. Other prominent growth factors include large number of clinical trials in the novel renal biomarker and drug development space and penetration of various cost-effective, reliable, and rapid technologically driven diagnostic protocols in clinical practice. However, use of unreliable imperfect gold standard for renal disease diagnosis and lack of sensitivity and specificity in current renal biomarkers are some of the factors restraining the growth of the market over the forecast period.
Current trends governing the global renal biomarker market include the possible use of renal biomarkers in personalised medicine and drug development and a growing popularity of non-invasive renal biomarkers.
By Biomarker Type
By Diagnostic Technique
By End User
| || || || |
Functional Biomarker type segment expected to remain the dominant segment over the forecast period
The Functional Biomarker segment is anticipated to account for a market value share of 52.3% by the end of 2016 and is expected to retain its dominance throughout the forecast period. The Up-Regulated Proteins segment is estimated to account for 33.8% market share in terms of value by 2016 end.
Enzyme Linked Immunosorbent Assay diagnostic technique segment estimated to hold the highest market share throughout the forecast period
The Enzyme Linked Immunosorbent Assay segment is anticipated to register a CAGR of 8.1% over the forecast period and is expected to register high Y-o-Y growth rates from 2016 to 2026. The Particle-Enhanced Turbidimetric Immunoassay segment is estimated to be the second largest segment in terms of value, holding a market value share of 21.0% by 2016 end.
Diagnostic Labs end user segment expected to witness highest growth in terms of revenue throughout the forecast period
The Diagnostic Labs segment is estimated to account for 34.2% market share of the global renal biomarker market in revenue terms by 2016 end and is expected to register high Y-o-Y growth rates throughout the forecast period. The Outpatient Clinics segment is anticipated to register a CAGR of 7.2% during the forecast period.
North America renal biomarker market expected to register high Y-o-Y growth throughout the forecast period
The North America regional market is estimated to account for 32.2% revenue share of the global renal biomarker market by 2016 end. Western Europe is estimated to hold the second largest market share of 21.1% by 2016 end.
Leading market players are emphasising on product innovation and strategic acquisitions to increase market share
Beckman Coulter, Inc. (Danaher Corporation), Thermo Fisher Scientific Inc., Abbott Laboratories, BIOPORTO A/S, Astute Medical, Inc., and Randox Laboratories Ltd. are some of the key players operating in the global renal biomarker market. Top market companies are focussing on increasing their presence in high-growth emerging markets through structured investments in R&D and technological innovation.
Future Market Insights examines the global renal biomarker market for the period 2016–2026 in a new report titled “Renal Biomarker Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” The primary objective of the report is to offer updates and in-depth analysis of market opportunities in the global renal biomarker market. The report offers a global market forecast in terms of value for the next 10 years.
To understand and assess opportunities in this market, the report is categorically split under four sections based on market segmentation – by biomarker type, diagnostic technique, end user, and region. The report analyses the global renal biomarker market in terms of market value (US$ Mn). The report begins with an overview of various types of renal diseases and addressable biomarker followed by a market forecast for the period 2016 – 2026. We have also presented a detailed analysis of key trends and drivers from the economic and supply and demand perspectives, market restraints, and trends likely to impact the global renal biomarker market. The subsequent sections analyse the global renal biomarker market on the basis of biomarker type, diagnostic technique, end user, and region and present a comprehensive forecast in terms of value for the next 10 years. Our study further discusses the key trends across the various assessed regions and analyses the degree to which drivers are influencing the market in each region.
In the final section of the report, we have included the global renal biomarker market competitive landscape to provide report audiences with a dashboard view of key renal biomarker providers, their presence in the global renal biomarker market, and key differentiators. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the global renal biomarker market. We have further profiled the leading players on the basis of various attributes such as company overview, recent developments, growth strategies, sustainability, and financial overview to evaluate their long- and short-term strategies, key offerings, and recent developments in the global renal biomarker market.
We have leveraged extensive secondary research to ascertain overall market size and top industry players. To arrive at the market size, the report considers average price of renal biomarker assays across geographies. The forecast presented here assesses the total revenue of the global renal biomarker market. When developing the market forecast, the starting point involves sizing the current market, which forms the basis for forecasting how the market is anticipated to take shape in the near future. Given the characteristics of the market, we have triangulated the outcome on the basis of supply and demand side analysis. The report also takes into consideration year-on-year growth to understand the predictability of the market and to identify the right opportunities across the global renal biomarker market.
Further, the different market segments have been analysed in terms of Basis Point Share (BPS) to understand individual segments’ relative contribution to market growth. This detailed level of information is important for the identification of various key trends governing the global renal biomarker market. Another key feature of our report is the analysis of the global renal biomarker market by region, biomarker type, diagnostic technique, and end user, and its revenue forecast in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective in the global renal biomarker market. Further, to understand key segments in terms of growth and performance in the global renal biomarker market, Future Market Insights has developed a market attractiveness index to help providers identify existing market opportunities across the global renal biomarker market.